人GABAA受体α4亚基的克隆与表征:鉴定一个独特的地西泮不敏感结合位点

Wu Yang, John A. Drewe, Nancy C. Lan
{"title":"人GABAA受体α4亚基的克隆与表征:鉴定一个独特的地西泮不敏感结合位点","authors":"Wu Yang,&nbsp;John A. Drewe,&nbsp;Nancy C. Lan","doi":"10.1016/0922-4106(95)90072-1","DOIUrl":null,"url":null,"abstract":"<div><p>Benzodiazepines modulate γ-aminobutyric acid (GABA)-evoked chloride currents through a specific binding site at the GABA<sub>A</sub> receptor-chloride channel complex. The heterogeneity of diazepam-sensitive benzodiazepine binding sites (type I and type II) has been identified by pharmacological approaches both with native receptors and recombinant receptors coexpressing α, β and γ subunits. In addition, two distinguishable diazepam-insensitive benzodiazepine sites arefound, spatially distributed between cerebral cortical and cerebellar regions. Coexpression of α6 with β2 and γ2L subunits creates a pharmacologically similar benzodiazepine receptor to the diazepam-insensitive site observed in cerebellum, however, there is no evidence regarding the possible subunit combination forming the DI site in cerebral tissues. Here we report the cloning of the human α4 cDNA and its pharmacology by coexpression of this α4 subunit with β2 and γ2L subunits. This recombinant receptor complex showed a high affinity for the previously described benzodiazepine partial agonist bretazenil, the pyrazoloquinoline compounds CGS-9895 and CGS-9896, as well as the inverse agonists DMCM (methyl 6,7-dimethoxy 4-ethyl-β-carboline-3-carboxylate) and Ro15-4513 as determined by [<sup>3</sup>H]Ro15-4513 binding. However, it is insensitive to the benzodiazepine type I selective compounds CL218,872 (3-methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-<em>b</em>]pyridazine) and zolpidem as well as the benzodiazepine full agonists diazepam, halazolam and midazolam. In addition, the benzodiazepine receptor ligands DMCM, β-CCE (β-carboline-3-carboxylate ethyl ester), β-CCM (β-carboline-3-carboxylate methyl ester), FG-7142, CGS-9895 and CGS-9896 showed 7 to 10 times higher affinity for α4β2γ2L than for α6β2γ2L. The pharmacology of the α4β2γ2L receptor complex appears to resemble those of the diazepam-insensitive site found in the cerebral cortex. Our study thus suggests that this subpopulation of diazepam-insensitive GABA<sub>A</sub> receptors may be composed of α4β2γ2L subunits.</p></div>","PeriodicalId":100502,"journal":{"name":"European Journal of Pharmacology: Molecular Pharmacology","volume":"291 3","pages":"Pages 319-325"},"PeriodicalIF":0.0000,"publicationDate":"1995-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0922-4106(95)90072-1","citationCount":"65","resultStr":"{\"title\":\"Cloning and characterization of the human GABAA receptor α4 subunit: identification of a unique diazepam-insensitive binding site\",\"authors\":\"Wu Yang,&nbsp;John A. Drewe,&nbsp;Nancy C. Lan\",\"doi\":\"10.1016/0922-4106(95)90072-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Benzodiazepines modulate γ-aminobutyric acid (GABA)-evoked chloride currents through a specific binding site at the GABA<sub>A</sub> receptor-chloride channel complex. The heterogeneity of diazepam-sensitive benzodiazepine binding sites (type I and type II) has been identified by pharmacological approaches both with native receptors and recombinant receptors coexpressing α, β and γ subunits. In addition, two distinguishable diazepam-insensitive benzodiazepine sites arefound, spatially distributed between cerebral cortical and cerebellar regions. Coexpression of α6 with β2 and γ2L subunits creates a pharmacologically similar benzodiazepine receptor to the diazepam-insensitive site observed in cerebellum, however, there is no evidence regarding the possible subunit combination forming the DI site in cerebral tissues. Here we report the cloning of the human α4 cDNA and its pharmacology by coexpression of this α4 subunit with β2 and γ2L subunits. This recombinant receptor complex showed a high affinity for the previously described benzodiazepine partial agonist bretazenil, the pyrazoloquinoline compounds CGS-9895 and CGS-9896, as well as the inverse agonists DMCM (methyl 6,7-dimethoxy 4-ethyl-β-carboline-3-carboxylate) and Ro15-4513 as determined by [<sup>3</sup>H]Ro15-4513 binding. However, it is insensitive to the benzodiazepine type I selective compounds CL218,872 (3-methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-<em>b</em>]pyridazine) and zolpidem as well as the benzodiazepine full agonists diazepam, halazolam and midazolam. In addition, the benzodiazepine receptor ligands DMCM, β-CCE (β-carboline-3-carboxylate ethyl ester), β-CCM (β-carboline-3-carboxylate methyl ester), FG-7142, CGS-9895 and CGS-9896 showed 7 to 10 times higher affinity for α4β2γ2L than for α6β2γ2L. The pharmacology of the α4β2γ2L receptor complex appears to resemble those of the diazepam-insensitive site found in the cerebral cortex. Our study thus suggests that this subpopulation of diazepam-insensitive GABA<sub>A</sub> receptors may be composed of α4β2γ2L subunits.</p></div>\",\"PeriodicalId\":100502,\"journal\":{\"name\":\"European Journal of Pharmacology: Molecular Pharmacology\",\"volume\":\"291 3\",\"pages\":\"Pages 319-325\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0922-4106(95)90072-1\",\"citationCount\":\"65\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmacology: Molecular Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0922410695900721\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmacology: Molecular Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0922410695900721","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 65

摘要

苯二氮卓类药物通过GABAA受体氯通道复合物的特定结合位点调节γ-氨基丁酸(GABA)诱发的氯电流。地西泮敏感的苯二氮卓类结合位点(I型和II型)的异质性已通过药理学方法鉴定,包括天然受体和共表达α、β和γ亚基的重组受体。此外,还发现了两个可区分的对二氮卓不敏感的苯二氮卓位点,其空间分布在大脑皮层和小脑区域之间。α6与β2和γ2L亚基的共表达产生了与小脑中观察到的地西泮不敏感位点在药理学上相似的苯二氮卓类受体,然而,没有证据表明可能的亚基组合在脑组织中形成DI位点。本文报道了人α4 cDNA的克隆及其与β2和γ2L亚基共表达的药理学。通过[3H]Ro15-4513结合测定,该重组受体复合物对先前描述的苯二氮卓类部分激动剂布他嗪、吡唑喹啉化合物CGS-9895和CGS-9896以及反向激动剂DMCM(甲基6,7-二甲氧基-4-乙基-β-卡波林-3-羧酸酯)和Ro15-451表现出高亲和力。然而,它对苯二氮卓I型选择性化合物CL218872(3-甲基-6-[3-(三氟甲基)苯基]-1,2,4-三唑并[4,3-b]哒嗪)和唑吡坦以及苯二氮卓全激动剂地西泮、哈拉唑仑和咪达唑仑不敏感。此外,苯二氮卓类受体配体DMCM、β-CCE(β-卡林-3-羧酸乙酯)、β-CCM(β-卡林-3-羧酸甲酯)、FG-7142、CGS-9895和CGS-9896对α4β2γ2L的亲和力是对α6β2γ2R的7至10倍。α4β2γ2L受体复合物的药理学似乎与大脑皮层中发现的地西泮不敏感位点的药理学相似。因此,我们的研究表明,这种对地西泮不敏感的GABAA受体亚群可能由α4β2γ2L亚基组成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cloning and characterization of the human GABAA receptor α4 subunit: identification of a unique diazepam-insensitive binding site

Benzodiazepines modulate γ-aminobutyric acid (GABA)-evoked chloride currents through a specific binding site at the GABAA receptor-chloride channel complex. The heterogeneity of diazepam-sensitive benzodiazepine binding sites (type I and type II) has been identified by pharmacological approaches both with native receptors and recombinant receptors coexpressing α, β and γ subunits. In addition, two distinguishable diazepam-insensitive benzodiazepine sites arefound, spatially distributed between cerebral cortical and cerebellar regions. Coexpression of α6 with β2 and γ2L subunits creates a pharmacologically similar benzodiazepine receptor to the diazepam-insensitive site observed in cerebellum, however, there is no evidence regarding the possible subunit combination forming the DI site in cerebral tissues. Here we report the cloning of the human α4 cDNA and its pharmacology by coexpression of this α4 subunit with β2 and γ2L subunits. This recombinant receptor complex showed a high affinity for the previously described benzodiazepine partial agonist bretazenil, the pyrazoloquinoline compounds CGS-9895 and CGS-9896, as well as the inverse agonists DMCM (methyl 6,7-dimethoxy 4-ethyl-β-carboline-3-carboxylate) and Ro15-4513 as determined by [3H]Ro15-4513 binding. However, it is insensitive to the benzodiazepine type I selective compounds CL218,872 (3-methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-b]pyridazine) and zolpidem as well as the benzodiazepine full agonists diazepam, halazolam and midazolam. In addition, the benzodiazepine receptor ligands DMCM, β-CCE (β-carboline-3-carboxylate ethyl ester), β-CCM (β-carboline-3-carboxylate methyl ester), FG-7142, CGS-9895 and CGS-9896 showed 7 to 10 times higher affinity for α4β2γ2L than for α6β2γ2L. The pharmacology of the α4β2γ2L receptor complex appears to resemble those of the diazepam-insensitive site found in the cerebral cortex. Our study thus suggests that this subpopulation of diazepam-insensitive GABAA receptors may be composed of α4β2γ2L subunits.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信